Psychosocial and behavioural determinants of the implementation of Pharmaceutical Care in Spain

Zardaín, Emma; Valle, Maria Olivo del; Loza, Marı́a Isabel; García, Eduardo; Lana, Alberto; Markham, Wolfgang A.; López, Marı́a Luisa

doi:10.1007/s11096-008-9275-7

Cited by 17 publications

(16 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…9 With the advent of these new abilities, renewed and increasingly urgent, calls have been made for all pharmacists to integrate these services into their daily practices, so that the value to the larger health system can be formally assessed. [10][11][12][13] Indeed, evolving and transforming how pharmacists' practice has been a preoccupation of the profession since the 1970s. 14,15 In that time, many studies have examined why substantial and sustained change has not taken place within the profession.…”

Section: Introductionmentioning

confidence: 99%

Identifying relationships between the professional culture of pharmacy, pharmacists' personality traits, and the provision of advanced pharmacy services

Rosenthal

Tsao

Tsuyuki

et al. 2016

Research in Social and Administrative Pharmacy

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Identifying relationships between the professional culture of pharmacy, pharmacists' personality traits, and the provision of advanced pharmacy services

Rosenthal

Tsao

Tsuyuki

et al. 2016

Research in Social and Administrative Pharmacy

View full text Add to dashboard Cite

“…Research suggests that pharmacists’ motivations to change exist on a spectrum from external pressure to change (such as response to threats to the business) to motivation based on professional satisfaction and belief in one's role as a health professional . Evidence shows increased professional satisfaction when pharmacists provide services such as medication and disease state management for chronic conditions such as asthma, diabetes, cardiovascular disease, obesity/weight management and addiction . Pharmacists who are confident in asking the right questions of consumers and approaching them in the appropriate way are more likely to continue these behaviours in the future .…”

Section: Introductionmentioning

confidence: 99%

Community pharmacy staff motivations and barriers to working with mental health consumers

Knox

Hattingh

Wheeler

2016

Pharmacy Practice and Res

View full text Add to dashboard Cite

Background Mental health is an Australian national priority area, yet evidence indicates pharmacy staff members focus more frequently on other chronic diseases. A need was identified to facilitate community pharmacy staff engagement with mental health initiatives. Aim This study explored community pharmacy staff motivations and barriers to working with mental health consumers and carers. Method A questionnaire assessing baseline attitudes, knowledge and skills towards mental illness was completed by 791 community pharmacy staff members. Participants rated their agreement with statements regarding factors that motivate them (11 items) or present a barrier to working with mental health consumers and carers (12 items) on a 7‐point Likert scale. Qualitative comments were invited. Results In total, 465 pharmacists (58.8%) and 326 support staff (41.2%) completed the questionnaire. Statements reflecting motivations were strongly endorsed: 83% of participants agreed that they were motivated to work with mental health consumers and carers, and 96% agreed that community pharmacists are integral members of the healthcare team. The most frequently endorsed barriers related to lack of training to assist people and belief that consumers feel ashamed about their illness. Themes that emerged from qualitative comments identified staff skills and knowledge as both motivators and barriers. Conclusion The findings identified that both pharmacists and pharmacy support staff required more training, confidence and practical strategies to support best practice in meeting the needs and expectations of mental health consumers and carers.

show abstract

“…Research into the reasons for this gap in the treatment of patients points to a number of barriers including a perceived lack of knowledge [ 15 ], confidence [ 16 ], time, and privacy [ 16 , 17 ]. Some work also suggests that pharmacists are tied to traditional dispensing models of practice [ 15 , 18 , 19 ], and that the physical environment and workflow of the pharmacy are mainly dispensing-oriented [ 20 ].…”

Section: Introductionmentioning

confidence: 99%

A cluster-randomized controlled knowledge translation feasibility study in Alberta community pharmacies using the PARiHS framework: study protocol

Rosenthal

Tsuyuki

Houle

2015

Pilot Feasibility Stud

View full text Add to dashboard Cite

BackgroundDespite evidence of benefit for pharmacist involvement in chronic disease management, the provision of these services in community pharmacy has been suboptimal. The Promoting Action on Research Implementation in Health Services (PARiHS) framework suggests that for knowledge translation to be effective, there must be evidence of benefit, a context conducive to implementation, and facilitation to support uptake. We hypothesize that while the evidence and context components of this framework are satisfied, that uptake into practice has been insufficient because of a lack of facilitation. This protocol describes the rationale and methods of a feasibility study to test a facilitated pharmacy practice intervention based on the PARiHS framework, to assist community pharmacists in increasing the number of formal and documented medication management services completed for patients with diabetes, dyslipidemia, and hypertension.MethodsA cluster-randomized before-after design will compare ten pharmacies from within a single organization, with the unit of randomization being the pharmacy. Pharmacies will be randomized to facilitated intervention based on the PARiHS framework or usual practice. The Alberta Context Tool will be used to establish the context of practice in each pharmacy. Pharmacies randomized to the intervention will receive task-focused facilitation from an external facilitator, with the goal of developing alternative team processes to allow the greater provision of medication management services for patients with diabetes, hypertension, and dyslipidemia. The primary outcome will be a process evaluation of the needs of community pharmacies to provide more clinical services, the acceptability and uptake of modifications made, and the willingness of pharmacies to participate. Secondary outcomes will include the change in the number of formal and documented medication management services in the aforementioned chronic conditions provided 6 months before, versus after, the intervention between the two groups, and identification of feasible quantitative outcomes for evaluating the effect of the intervention on patient care outcomes.ResultsTo date, the study has identified and enrolled the ten pharmacies required and initiated the intervention process.ConclusionThis study will be the first to examine the role of facilitation in pharmacy practice, with the goal of scalable and sustainable practice change.Trial registrationClinicaltrials.gov identifier NCT02191111.

show abstract

Psychosocial and behavioural determinants of the implementation of Pharmaceutical Care in Spain

Cited by 17 publications

References 31 publications

Identifying relationships between the professional culture of pharmacy, pharmacists' personality traits, and the provision of advanced pharmacy services

Identifying relationships between the professional culture of pharmacy, pharmacists' personality traits, and the provision of advanced pharmacy services

Community pharmacy staff motivations and barriers to working with mental health consumers

A cluster-randomized controlled knowledge translation feasibility study in Alberta community pharmacies using the PARiHS framework: study protocol

Contact Info

Product

Resources

About